Stay updated on Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a new version of the page. This reflects a small, internal update to the page's rendering or metadata.
    Difference
    0.1%
    Check dated 2026-08-11T08:12:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    No additions or deletions were recorded in the changes data. This indicates that the page content, as represented by the input, shows no change.
    Difference
    0.0%
    Check dated 2026-08-04T09:00:17.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4 across the page. This indicates a minor platform update and does not modify the study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-07-28T05:16:18.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page shows a new revision tag, updating from v3.6.2 to v3.6.3 to reflect a minor page update.
    Difference
    0.0%
    Check dated 2026-07-06T18:17:55.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.6.2 tag appears on the page, replacing the previous v3.6.0 tag. This reflects a behind-the-scenes update to the page version without altering the displayed study details.
    Difference
    0.0%
    Check dated 2026-06-29T14:47:27.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page now shows a recruitment closure note ('No longer looking for participants'), and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Study Details heading formatting changes from 'Intervention / Treatment' to 'Intervention/Treatment' to reflect a consistency update.
    Difference
    0.3%
    Check dated 2026-06-15T08:34:38.000Z thumbnail image

Stay in the know with updates to Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegilodecakin Combo vs Pembrolizumab Alone in NSCLC Clinical Trial page.